Human medicines European public assessment report (EPAR): Mynzepli, aflibercept, Date of authorisation: 18/08/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Eyluxvi, aflibercept, Date of authorisation: 15/09/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 41, Status: Authorised

Human medicines European public assessment report (EPAR): Eiyzey, aflibercept, Date of authorisation: 14/08/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Afiveg, aflibercept, Date of authorisation: 18/08/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Baiama, aflibercept, Date of authorisation: 13/01/2025, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Eydenzelt, aflibercept, Date of authorisation: 12/02/2025, Revision: 6, Status: Authorised

Agenda - 21st industry stakeholder platform - operation of EU pharmacovigilance

Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 6, Status: Authorised

Reflection paper on methodological aspects in confirmatory platform trials